Rodríguez-Violante M, Cervantes-Arriaga A, Arellano-Reynoso A

Idioma: Español
Referencias bibliográficas: 33
Paginas: 157-162
Archivo PDF: 124.38 Kb.

RESUMEN

La estimulación cerebral profunda (ECP) de blancos específicos es una opción terapéutica cada vez más utilizada en el manejo de pacientes con enfermedad de Parkinson. La tasa de éxito depende de diversos factores en los que destaca la participación del neurocirujano y del neurólogo; sin embargo, cada vez es más claro que se requiere de un equipo multidisciplinario para una correcta selección del candidato; así como para la detección y manejo de posibles complicaciones previo, durante y posterior a una cirugía de colocación de un estimulador cerebral profundo. La creación de un equipo conformado por neurólogo, neurofisiólogo, neurocirujano funcional, neuropsicólogo, neuropsiquiatra e internista y su correcta interacción en el periodo perioperatorio son clave para disminuir el riesgo de complicaciones y obtener un desenlace satisfactorio. En el presente trabajo se destaca la participación y el papel a desarollar por cada uno de los miembros de este equipo multidisciplinario en el contexto de la cirugía de estimulación cerebral profunda en el paciente con enfermedad de Parkinson.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Okun MS, Tagliati M, Pourfar M, et al. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol 2005; 62: 1250-5. Rodríguez-Violante M, et al. Estimulación profunda en EP 162 Rev Mex Neuroci Mayo-Junio, 2014; 15(3): 157-162

2. Chan DT, Zhu XL, Yeung JH, Mok VC, Wong E, Lau C, et al. Complications of deep brain stimuation: a collective review. Asian J Surg 2009; 32: 258-63.

3. Okun MS, Foote KD. Parkinson’s disease DBS: what, when, who and why? The time has come to tailor DBS tagets. Expert Rev Neurother 2010; 10: 1847-57.

4. Groiss SJ, Wojtecki L, Südmeyer M, Schnitzler A. Deep brain stimulation in Parkinson’s disease. Ther Adv Neurol Disord 2009; 2: 20-8.

5. Mendes MV, Coste J, Derost P, Ulla M, Gabrillarques J, Durif F, et al. Surgical complications of deep brain stimulation: clinical experience of 184 cases. Neurochirurgie 2012; 58: 219-24.

6. Hariz MI. Complications of deep brain stimulation surgery. MovDisord 2002; 17: 162–166. 89 y Oh MY, Abosch A, Kim SH, Lang AE, Lozano AM. Long-termhardware-related complications of deep brain stimulation. Neurosurgery 2002; 50: 1268-74.

7. Umemura A, Jaggi JL, Hurtig HI, et al. Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. J Neurosurg 2003; 98: 779-84.

8. Beric A, Kelly PJ, Rezai A, et al. Complications of deep brain stimulation surgery. Stereotact Funct Neurosurg 2001; 77: 73-8.

9. Starr PA, Christine CW, Theodosopoulos PV, et al. Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead loca- tions. J Neurosurg 2002; 97: 370-87.

10. Shih LC, Tarsy D. Deep brain stimulation for the treatment of atypical parkinsonism. Mov Disord 2007; 22: 2149-55.

11. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clínico-pathological study of 100 cases. Neurol Neurosurg Psychatry 1992; 55: 181-4

12. Feldman AL, Johansson AL, Gatz M, Flensburg M, Petzinger GM, Widner H, Lew MF, et al. Accuracy and sensitivity of parkinsonian diagnoses in two Swedish national health registers. Neuroepidemiology 2012; 38: 186-93.

13. Bajaj NP, Gontu V, Birchall J, Patterson J, Grosset DG, Lees AJ. Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study. J Neurol Neurosurg Psychiatry 2010; 81(11): 1223-8.

14. Morishita T, Rahman M, Foote KD, Fargen KM, Jacobson CE 4th, Fernandez HH, et al. DBS candidates that fall short on a levodopa challenge test: alternative and important indications. Neurologist 2011; 263-8.

15. Follet KA. Comparison of pallidal and subthalamicdeep brain stimulation for the treatment of levodopa-induced dyskinesias. Neurosurg Focus 2004; 17: 14-9.

16. Bour LJ, Contarino MF, Foncke EM, de Bie RM, van den Munckhof P, Speelman JD, Schuurman PR. Long-term experience with intraoperative microrecording during DBS neurosurgery in STN and GPi. Acta Neurochir (Wien) 2010; 152: 2069-77.

17. Ondo W, Bronte-Stewart H: The North American survey of placement and adjustment techniques for deep brain stimulation. Neurology 2004; 62(Suppl. 5): A393.

18. Starr PA, Christine CW, Theodosopoulos PV, Lindsey N, Byrd D, Mosley A, Marks WJ Jr. Implantation of deep brain stimulator electrodes into the subthalamic nucleus: Technical approach and magnetic resonance imaging-verified electrode locations. J Neurosurg 2002; 97: 370-87.

19. Okun MS, Rodriguez RL, Mikos A, Miller K, Kellison I, Kirsch-Darrow L, et al. Deep brain stimulation and the role of the neuropsychologist. Clin Neuropsychol 2007; 21: 162-89.

20. Troster AI. Neuropsychology of deep brain stimulation in neurology and psychiatry. Front Biosci 2009; 14: 1857-79.

21. Witt K, Daniels C, Reiff J, Krack P, Volkmann J, Pinkser MO, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: a randomised, multicentre study. Lancet Neurol 2008; 7: 605-14.

22. Lipsman N, Gerretsen P, Torres C, Lozano AM, Giacobbe P. A psychiatric primer for the functional neurosurgeon. J Neurosurg Sci 2012; 56: 209-22.

23. Herzog J, Volkmann J, Krack P, et al. Two-year follow-up of subthalamic deep brain stimulation in Parkinson’s disease. Mov Disord 2003; 18: 1332-7.

24. Demetriades P, Rickards H, Cavanna AE. Impulse control disorders following deep brain stimulation of the subthalamic nucleus in Parkinson’s disease: clinical aspects. Parkinsons Dis 2011; 2011: 658415

25. Chopra A, Tye SJ, Lee KH, Sampson S, Matsumoto J, Adams A, et al. Underlying neurobiology and clinical correlates of mania status after subthalamic nucleus deep brain stimulation in Parkinson’s disease: a review of the literature. J Neuropsuchiatry Clin Neurosci 2012; 24: 102-10.

26. Mathews DJ. Deep brain stimulation, personal identity and policy. Int Rev Psychiatry 2011; 23: 486-92.

27. Binder DK, Rau G, PA S. Hemorrhagic complications of microelectrode- guided deep brain stimulation. Stereotact Funct Neurosurg 2003; 80: 28-31.

28. Saeleau P, Leray E, Rouaud T, Drapier S, Drapier D, Blanchard S, et al. Comparison of weight gain and energy intake after subthalamic versus pallidal stimulation in Parkinson’s disease. Mov Disord 2009; 24: 2149-55.

29. Capecci M, Passamonti L, Annesi F, et al. Chronic bilateral subthalamic deep brain stimulation in a patient with homozygous deletion in the parkin gene. Mov Disord 2004; 19: 1450-2.

30. Johnston M, Che E. Does attendance at a multidisciplinary outpatient rehabilitation program for people with Parkinson’s disease produce quantitative short term or long term improvements? A systematic review. Neurorehabilitation 2010; 26: 375-83

31. Stewart RM, Desaloms JM, Sanghera MK. Stimulation of the subthalamic nucleus for the treatment of Parkinson’s disease: postoperative management, programming, and rehabilitation. J Neurosci Neurosurg 2005; 37: 108-14.

32. Post B, van der Eijk M, Munneke M, Bloem BR. Multidisciplinary care of Parkinson’s disease: not if, but how! Postgrad Med J 2011; 87: 575-8.

33. Martínez-Ramírez D, Okun MS. Rationale and clinical pearls for primary care doctors referring patients for Deep brain stimulation. Gerontology 2103; En prensa.